Reasons may be that tumor cells can evade immunomediated recognition through new pathways and PD-1 and CTLA-4 blockade can also cause up-regulation of other immune inhibitory receptors like VISTA and TIM-3 [71,72]. This evidence concerns the gene CTLA4 and neoplasm.